Y Zevalin and BEAM in Autologous Stem Cell Transplantation (ASCT) for Lymphoma

NCT01538472 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: Y Zevalin
DRUG: In Zevalin
DRUG: Rituxan
DRUG: BCNU
DRUG: VP -16
DRUG: Ara-C
DRUG: Melphalan
PROCEDURE: Stem Cell Infusion
DRUG: G-CSF

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]